ProSci PUMA Antibodies
03 April, 2023ProSci's PUMA antibody preparations have been validated for western blot, ELISA, immunocytochemistry and immunofluorescence.
Blood–brain barrier model used to test antibodies
13 March, 2023The artificial blood–brain barrier model can be used to determine how well antibody-based therapies can enter the brain.
Antibody's unexpected response to Strep A infection
12 January, 2023Scientists at Lund University have discovered a rare form of antibody binding that leads to an effective immune response against group A streptococcus bacteria.
ProSci research-grade biosimilars
09 January, 2023Researchers use monoclonal antibodies, also known as biosimilars, as tools to research novel therapies and uncover effective off-target applications.
GeneTex infectious diseases antibodies
08 December, 2022GeneTex offers an extensive catalogue of antibody reagents that can facilitate research into several viruses.
The Native Antigen Company 2023 Southern Hemisphere flu season antigens
16 November, 2022The Native Antigen Company has announced that haemagglutinin (HA) and neuraminidase (NA) antigens are now available to cover the 2023 Southern Hemisphere vaccine formulation.
Bio-Rad Laboratories Pioneer Antibody Discovery Platform
16 November, 2022Bio-Rad Laboratories has launched its Pioneer Antibody Discovery Platform, an antibody discovery service specifically designed to develop best-in-class biologic candidates.
Proteintech FlexAble antibody labelling kits
01 November, 2022FlexAble from Proteintech is a novel antibody labelling kit for immunofluorescence (IF), western blot (WB) and flow cytometry (FC). The kits use an affinity linker to conjugate fluorochromes, enzymes and molecules to the user's chosen antibody in any buffer condition.
Antibodies from former COVID patients neutralise Delta, Omicron
23 September, 2022Antibodies isolated from the immune system of recovered COVID-19 patients are effective in neutralising all known strains of the virus, including Delta and Omicron.
WHO strongly advises against antibody drugs to treat COVID-19
16 September, 2022The antibody drugs sotrovimab and casirivimab-imdevimab are no longer recommended for patients with COVID-19.
ProSci poxvirus research tools
09 September, 2022Many viruses in the Poxviridae family have genetic similarities, allowing many of the same research tools to be used on multiple viral species.
Bio-Rad Laboratories anti-evolocumab antibodies
29 August, 2022The sequence-defined, recombinant antibodies are suitable for developing highly selective and sensitive pharmacokinetic (PK) and anti-drug antibody (ADA) assays for evolocumab and its biosimilars.
Abcalis Multiclonal Recombinant Secondary Antibodies
10 August, 2022Multiclonals consist of defined mixtures of carefully selected individual recombinant monoclonal antibodies, recognising different epitopes on all four different subclasses of human IgG.
GeneTex ion channel antibodies
09 August, 2022GeneTex offers a wide selection of antibodies to support ion channel research, with IHC-validated and/or ICC/IF-validated antibodies to facilitate research efforts in this field.
The Native Antigen Company monkeypox antigens
26 July, 2022The Native Antigen Company has moved to develop a series of monkeypox antigens to support research into this disease.
